Report Categories
View AllRecent Articles
View All
Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surges Past Expectations by 315 Stock Edges Lower
INBS Q1 2025 Earnings Significant EPS Miss Amidst No Revenue Disclosure
Biohaven BHVN Q1 2026 Earnings EPS Slightly Misses Estimates as Pipeline Momentum Builds
SAM Q1 2026 Earnings EPS Misses Estimates Stock Still Gains Ground
IRTC Q1 2026 Earnings EPS Beat by 47 Amid Ongoing Revenue Uncertainty